ReviewAdvanced healthcare materials2026
Recapitulating Endochondral Ossification for Bone Repair: From Development to Engineering Strategy.
Review in Advanced healthcare materials, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
Endochondral ossification (ECO) is the fundamental mechanism underlying long bone development and fracture healing, driven by a cartilage template that orchestrates highly ordered cellular differentiation, vascular invasion, and matrix remodeling. In recent years, ECO has emerged as a key strategy in bone tissue engineering (BTE) due to its remarkable potential in constructing vascularized bone and repairing large bone defects. This review centers on the strategies to recapitulate ECO, beginning with an overview of the essential biological events and molecular regulatory networks that define this process. We then highlight state-of-the-art strategies for inducing or mimicking ECO in vitro from a tissue engineering perspective, including seed cell selection and programming, biomaterial scaffold design and fabrication, and the delivery and dynamic regulation of bioactive factors, and propose potential improvement strategies based on the limitations of current engineering approaches. In addition, bibliometric analysis is employed to delineate research hotspots and development trends. Looking ahead, the refinement of in vitro engineering strategies may enable precise control of key events in the ECO process, providing more efficient, controllable, and physiologically relevant solutions for large bone defect repair.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.